What’s New From Oncolytics Biotech, Inc (NASDAQ:ONCY)?

1002

 Dallas, Texas 03/25/2014 (FINANCIALSTRENDS) –  Oncolytics Biotech, Inc (NASDAQ:ONCY) announced that it has now entered into a share- purchase agreement with the Lincoln Park Capital Fund, LLC that will now provide the initial investment in Oncolytics of US$1.0M and make available the additional periodic-investments of upto US$25.0M over the 30-month term. Upon execution of this Purchase Agreement , Oncolytics Biotech, Inc (NASDAQ:ONCY) received the investment of US$1.0M in exchange for issuance of the 600,962 common-shares to LPC at the per-share purchase price of US$1.664. Apart from this, subject to terms & conditions of this Purchase Agreement, Oncolytics Biotech, Inc (NASDAQ:ONCY), at its sole discretion, might sell upto US$25.0 M worth of its common- shares to the LPC over its 30-month term.

This purchase price of its common shares will now be based on the prevailing market-prices of Oncolytics Biotech, Inc (NASDAQ:ONCY)’s common shares that will be immediately preceding this notice of the sale without any kind of fixed discount. Subject to its Purchase Agreement, Oncolytics Biotech, Inc (NASDAQ:ONCY) controls the timing & the amount of any future investment & LPC is now obligated to make this purchases, if & when its elects. The Purchase- Agreement does not actually impose any other upper-price limit restrictions, negative- covenants or any restrictions on its future-financing activities.

Oncolytics Biotech, Inc (NASDAQ:ONCY) can also terminate this Purchase Agreement at any given time at the sole discretion without any kind of monetary cost/ penalty. Oncolytics will issue a commitment-fee in its common shares to LPC in relation with the Purchase-Agreement & on a pro-rata basis as the US$26,000,000 is funded by LPC. LPC has also agreed not to cause, or engage in any other manner whatsoever in, any kind of direct/ indirect short-selling/ hedging of Oncolytics Biotech, Inc (NASDAQ:ONCY)’s common shares. President& Chief Executive Officer of the company, Dr. Brad Thompson said that they are pleased that they have entered into the share-purchase agreement with the Lincoln Park Capital.

Subscribe to get your free report!

* indicates required
*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.